Ana Laín

1.0k total citations
19 papers, 636 citations indexed

About

Ana Laín is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Ana Laín has authored 19 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Infectious Diseases and 6 papers in Epidemiology. Recurrent topics in Ana Laín's work include Porphyrin Metabolism and Disorders (5 papers), Antifungal resistance and susceptibility (5 papers) and Fungal Infections and Studies (5 papers). Ana Laín is often cited by papers focused on Porphyrin Metabolism and Disorders (5 papers), Antifungal resistance and susceptibility (5 papers) and Fungal Infections and Studies (5 papers). Ana Laín collaborates with scholars based in Spain, United States and France. Ana Laín's co-authors include Óscar Millet, David Castaño, Blanca López‐Méndez, Xavier Tadeo, José Pontón, Marı́a D. Moragues, Gabriel Ortega, Natalia Elguezábal, Rubén Gil‐Redondo and José M. Mato and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Ana Laín

19 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Laín Spain 13 394 219 129 68 59 19 636
Stuart Rison United Kingdom 13 517 1.3× 239 1.1× 202 1.6× 66 1.0× 11 0.2× 23 840
Jeremiah W. Hanes United States 16 610 1.5× 343 1.6× 137 1.1× 125 1.8× 43 0.7× 26 1.1k
Weihao Zheng China 15 286 0.7× 92 0.4× 106 0.8× 20 0.3× 16 0.3× 29 656
Martin Fisher United Kingdom 8 407 1.0× 302 1.4× 49 0.4× 124 1.8× 19 0.3× 10 830
Xiuna Yang China 20 596 1.5× 360 1.6× 202 1.6× 61 0.9× 20 0.3× 44 1.1k
Mark McCann United States 20 548 1.4× 108 0.5× 191 1.5× 49 0.7× 39 0.7× 30 1.2k
Vincenzo Carbone Australia 18 339 0.9× 202 0.9× 40 0.3× 47 0.7× 7 0.1× 48 888
Albert D. Friesen Canada 14 322 0.8× 50 0.2× 56 0.4× 27 0.4× 19 0.3× 26 619
James W. Boles United States 10 335 0.9× 213 1.0× 101 0.8× 8 0.1× 45 0.8× 14 685
David Krause United States 8 368 0.9× 420 1.9× 73 0.6× 8 0.1× 66 1.1× 11 1.0k

Countries citing papers authored by Ana Laín

Since Specialization
Citations

This map shows the geographic impact of Ana Laín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Laín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Laín more than expected).

Fields of papers citing papers by Ana Laín

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Laín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Laín. The network helps show where Ana Laín may publish in the future.

Co-authorship network of co-authors of Ana Laín

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Laín. A scholar is included among the top collaborators of Ana Laín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Laín. Ana Laín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bizkarguenaga, Maider, Rubén Gil‐Redondo, Chiara Bruzzone, et al.. (2022). Prospective Metabolomic Studies in Precision Medicine: The AKRIBEA Project. Handbook of experimental pharmacology. 277. 275–297. 3 indexed citations
2.
Laín, Ana, Jordi To‐Figueras, Borja Mateos, et al.. (2022). ALAD Inhibition by Porphobilinogen Rationalizes the Accumulation of δ-Aminolevulinate in Acute Porphyrias. Biochemistry. 61(21). 2409–2416. 5 indexed citations
3.
Macías, Iratxe, Luca Unione, Ganeko Bernardo‐Seisdedos, et al.. (2021). Therapeutic Targeting of Fumaryl Acetoacetate Hydrolase in Hereditary Tyrosinemia Type I. International Journal of Molecular Sciences. 22(4). 1789–1789. 3 indexed citations
4.
Bizkarguenaga, Maider, Chiara Bruzzone, Rubén Gil‐Redondo, et al.. (2021). Uneven metabolic and lipidomic profiles in recovered COVID‐19 patients as investigated by plasma NMR metabolomics. NMR in Biomedicine. 35(2). e4637–e4637. 37 indexed citations
5.
Bruzzone, Chiara, Maider Bizkarguenaga, Rubén Gil‐Redondo, et al.. (2020). SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum. iScience. 23(10). 101645–101645. 151 indexed citations
6.
Bruzzone, Chiara, Maider Bizkarguenaga, Rubén Gil‐Redondo, et al.. (2020). SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum. SSRN Electronic Journal. 5 indexed citations
7.
Macías, Iratxe, Ana Laín, Ganeko Bernardo‐Seisdedos, et al.. (2019). Hereditary tyrosinemia type I–associated mutations in fumarylacetoacetate hydrolase reduce the enzyme stability and increase its aggregation rate. Journal of Biological Chemistry. 294(35). 13051–13060. 13 indexed citations
8.
Unione, Luca, María Pia Lenza, Ana Ardá, et al.. (2019). Glycoprofile Analysis of an Intact Glycoprotein As Inferred by NMR Spectroscopy. ACS Central Science. 5(9). 1554–1561. 34 indexed citations
9.
Bdira, Fredj Ben, Esperanza González, Ana Laín, et al.. (2014). Tuning intracellular homeostasis of human uroporphyrinogen III synthase by enzyme engineering at a single hotspot of congenital erythropoietic porphyria. Human Molecular Genetics. 23(21). 5805–5813. 16 indexed citations
10.
Blouin, Jean‐Marc, Yann Duchartre, Pierre Costet, et al.. (2013). Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria. Proceedings of the National Academy of Sciences. 110(45). 18238–18243. 27 indexed citations
11.
Castaño, David, et al.. (2011). Structural, thermodynamic, and mechanistical studies in uroporphyrinogen III synthase:Molecular basis of congenital erythropoietic porphyria. Advances in protein chemistry and structural biology. 83. 43–74. 12 indexed citations
12.
Ortega, Gabriel, Ana Laín, Xavier Tadeo, et al.. (2011). Halophilic enzyme activation induced by salts. Scientific Reports. 1(1). 6–6. 57 indexed citations
13.
Tadeo, Xavier, et al.. (2009). Structural Basis for the Aminoacid Composition of Proteins from Halophilic Archea. PLoS Biology. 7(12). e1000257–e1000257. 135 indexed citations
14.
Laín, Ana, Natalia Elguezábal, Elena Amutio, et al.. (2008). Use of Recombinant Antigens for the Diagnosis of Invasive Candidiasis. SHILAP Revista de lepidopterología. 2008. 1–7. 25 indexed citations
15.
Laín, Ana, Natalia Elguezábal, Marı́a D. Moragues, et al.. (2008). Contribution of serum biomarkers to the diagnosis of invasive candidiasis. Expert Review of Molecular Diagnostics. 8(3). 315–325. 14 indexed citations
16.
Castaño, David, et al.. (2008). Uroporphyrinogen III Synthase Mutations Related to Congenital Erythropoietic Porphyria Identify a Key Helix for Protein Stability. Biochemistry. 48(2). 454–461. 27 indexed citations
17.
Laín, Ana, Natalia Elguezábal, Juan Carlos García‐Ruiz, et al.. (2007). Diagnosis of invasive candidiasis by enzyme-linked immunosorbent assay using the N-terminal fragment of Candida albicans hyphal wall protein 1. BMC Microbiology. 7(1). 35–35. 34 indexed citations
18.
Laín, Ana, Marı́a D. Moragues, Juan Carlos García‐Ruiz, et al.. (2007). Evaluation of a Novel Enzyme-Linked Immunosorbent Assay To Detect Immunoglobulin G Antibody to Enolase for Serodiagnosis of Invasive Candidiasis. Clinical and Vaccine Immunology. 14(3). 318–319. 30 indexed citations
19.
Elguezábal, Natalia, Fernando Lopitz‐Otsoa, Ana Laín, et al.. (2005). Serodiagnosis of Mycoses Using Recombinant Antigens. Mycopathologia. 160(2). 97–109. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026